Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis

In this study we describe the immunogenicity results from a subset of older people (N = 5187) who participated in a Phase 3 randomized, observer-blinded trial of AS03-TIV versus TIV (Fluarix™) (ClinicalTrials.gov, NCT00753272). Participants received one dose of AS03-TIV or TIV in each study year and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human vaccines & immunotherapeutics 2016-12, Vol.12 (12), p.3043-3055
Hauptverfasser: Ruiz-Palacios, Guillermo M., Leroux-Roels, Geert, Beran, Jiri, Devaster, Jeanne-Marie, Esen, Meral, Launay, Odile, McElhaney, Janet E., van Essen, Gerrit A., Benoit, Anne, Claeys, Carine, Dewé, Walthère, Durand, Christelle, Duval, Xavier, Falsey, Ann R., Feldman, Gregory, Galtier, Florence, Gervais, Pierre, Hwang, Shinn-Jang, McNeil, Shelly, Richardus, Jan Hendrik, Trofa, Andrew, Oostvogels, Lidia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!